None listed
Conditions
Brief summary
The present project aims to examine the acute and long-term effects of high-intensity interval aerobic training (HIIT) and resistance exercise (RE) under hypoxic and normoxic conditions. The study will evaluate their impacts on muscle and cognitive functions, exploring mechanisms through myokine activity and mitochondria-related molecular biomarkers in older adults with sarcopenia.
Interventions
Intervention Arm 1: HIIT/RE under Hypoxia Description: Participants in this group undergo 60 minutes of hypoxic breathing (resting) followed immediately by 30 minutes of exercise. The exercise consists of either High-Intensity Interval Training (HIIT) on a treadmill or Resistance Exercise (RE) using resistance bands targeting both upper and lower limbs. The intervention is conducted over a total of 8 weeks with a frequency of 3 sessions per week. Administration and Monitoring: All sessions are conducted in a one-on-one format under the direct supervision of a physiotherapist. Exercise intensity is assessed and monitored using the Rating of Perceived Exertion (RPE) scale to ensure participants reach the target effort levels. To monitor adherence, a session attendance checklist is maintained by the supervising physiotherapist for every participant throughout the 24-session program. Intervention Arm 2: HIIT/RE under Normoxia Description: Participants in this group undergo 60 minutes of breathing normal room air (normoxia) followed immediately by 30 minutes of exercise. Similar to the hypoxic group, the exercise involves treadmill-based HIIT or RE using resistance bands for upper and lower limb strengthening. The program duration is 8 weeks, with 3 sessions per week. Administration and Monitoring: Sessions are delivered one-on-one and are supervised by a physiotherapist. The level of intensity is consistently assessed using the RPE scale. Adherence is strictly monitored via a session attendance checklist to track completion of the 8-week intervention.
Sponsors
Study design
Eligibility
Inclusion criteria
articipants must be older adults aged 65 to 85 years diagnosed with sarcopenia who are able to maintain their usual level of physical activity, medication, and nutritional intake throughout the study. Eligible individuals must have completed at least 9 years of formal education and demonstrate normal cognitive function, defined by a Montreal Cognitive Assessment (MoCA) score greater than 26 and a Mini-Mental State Examination (MMSE) score greater than 24. Furthermore, participants must be independent in their activities of daily living, possess normal or corrected-to-normal vision without other ocular comorbidities, and be cleared for both hypoxic exercise interventions and neurocognitive testing through a routine physical examination.
Exclusion criteria
ndividuals will be excluded if they have uncontrolled hypertension (systolic blood pressure > 180 mmHg or diastolic blood pressure > 100 mmHg), chronic obstructive pulmonary disease (COPD), malignant tumors, decompensated heart failure, or a history of head trauma or intracranial hemorrhage. Potential participants with psychiatric disorders or mental impairments, such as depression (indicated by a Beck Depression Inventory-II score > 13), or those currently taking anticonvulsants or corticosteroids will also be excluded. Additional exclusion criteria include acute inflammation of the lower back, lower limbs, or pelvis; other musculoskeletal or neurological issues; and acute renal, cardiovascular, metabolic, or bone-related diseases, including unstable arrhythmias or unstable vital signs.